Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synthetic peripherally-restricted cannabinoid suppresses chemotherapy-induced peripheral neuropathy pain symptoms by CB1 receptor activation
Yatendra Mulpuri, Vincent Marty, Joseph J. Munier, et al.
Neuropharmacology (2018) Vol. 139, pp. 85-97
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history
Sara Anna Bonini, Marika Premoli, Simone Tambaro, et al.
Journal of Ethnopharmacology (2018) Vol. 227, pp. 300-315
Closed Access | Times Cited: 571
Chemotherapy-induced peripheral neuropathy: where are we now?
Lesley Colvin
Pain (2019) Vol. 160, Iss. 1, pp. S1-S10
Open Access | Times Cited: 227
The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases
Henry Lowe, Ngeh J. Toyang, Blair Steele, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9472-9472
Open Access | Times Cited: 201
Cannabinoids, the endocannabinoid system, and pain: a review of preclinical studies
David P. Finn, Simon Haroutounian, Andrea G. Hohmann, et al.
Pain (2021) Vol. 162, Iss. 1, pp. S5-S25
Open Access | Times Cited: 162
A cryptic pocket in CB1 drives peripheral and functional selectivity
Vipin Ashok Rangari, Evan S. O’Brien, Alexander S. Powers, et al.
Nature (2025)
Closed Access | Times Cited: 2
A Guide to Targeting the Endocannabinoid System in Drug Design
Adam Stasiulewicz, Katarzyna Znajdek, Monika Grudzień, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 8, pp. 2778-2778
Open Access | Times Cited: 102
Sex differences and the endocannabinoid system in pain
Henry Blanton, Robert C. Barnes, Melissa C. McHann, et al.
Pharmacology Biochemistry and Behavior (2021) Vol. 202, pp. 173107-173107
Open Access | Times Cited: 97
Treatment and diagnosis of chemotherapy-induced peripheral neuropathy: An update
Allison D. Desforges, Chance M. Hebert, Allyson L. Spence, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 147, pp. 112671-112671
Open Access | Times Cited: 63
Discovery and Preclinical Evaluation of a Novel Inhibitor of FABP5, ART26.12, Effective in Oxaliplatin-Induced Peripheral Neuropathy
W. G. Warren, Myles Osborn, Christopher Tsantoulas, et al.
Journal of Pain (2024) Vol. 25, Iss. 7, pp. 104470-104470
Closed Access | Times Cited: 8
Orally consumed cannabinoids provide long-lasting relief of allodynia in a mouse model of chronic neuropathic pain
Antony D. Abraham, Edward J. Y. Leung, Brenden A. Wong, et al.
Neuropsychopharmacology (2019) Vol. 45, Iss. 7, pp. 1105-1114
Open Access | Times Cited: 67
Cannabinoids: Current and Future Options to Treat Chronic and Chemotherapy-Induced Neuropathic Pain
Henry Blanton, Jennifer Brelsfoard, Nathan Deturk, et al.
Drugs (2019) Vol. 79, Iss. 9, pp. 969-995
Open Access | Times Cited: 63
Pharmacological management of cancer pain: Novel therapeutics
Celina G. Virgen, Neil Kelkar, Aaron Tran, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113871-113871
Closed Access | Times Cited: 37
Chemotherapy-Induced Peripheral Neuropathy: A Recent Update on Pathophysiology and Treatment
Marina Mattar, Florence Umutoni, Ahmed S. Hassan, et al.
Life (2024) Vol. 14, Iss. 8, pp. 991-991
Open Access | Times Cited: 7
Recent advances in understanding chemotherapy-induced peripheral neuropathy
Richard Gordon-Williams, Paul Farquhar-Smith
F1000Research (2020) Vol. 9, pp. 177-177
Open Access | Times Cited: 44
Cannabis and cannabinoids in cancer pain management
Howard Meng, Tianyang Dai, John G. Hanlon, et al.
Current Opinion in Supportive and Palliative Care (2020) Vol. 14, Iss. 2, pp. 87-93
Closed Access | Times Cited: 41
Cannabigerol (CBG) attenuates mechanical hypersensitivity elicited by chemotherapy‐induced peripheral neuropathy
Diana E. Sepúlveda, Daniel P. Morris, Wesley M. Raup‐Konsavage, et al.
European Journal of Pain (2022) Vol. 26, Iss. 9, pp. 1950-1966
Closed Access | Times Cited: 25
Effect of cannabinoids on the efficacy and side effects of anticancer therapeutic strategies – Current status of preclinical and clinical research
Robert Ramer, Burkhard Hinz
Pharmacology & Therapeutics (2025), pp. 108851-108851
Closed Access
The Peripheral Cannabinoid Receptor Type 1 (CB1) as a Molecular Target for Modulating Body Weight in Man
Saoirse E. O’Sullivan, Andrew Yates, Richard K. Porter
Molecules (2021) Vol. 26, Iss. 20, pp. 6178-6178
Open Access | Times Cited: 29
Therapeutic potential of cannabinoids in combination cancer therapy
Pratibha Malhotra, Ilaria Casari, Marco Falasca
Advances in Biological Regulation (2021) Vol. 79, pp. 100774-100774
Closed Access | Times Cited: 27
Targeting sensory neuron GPCRs for peripheral neuropathic pain
Ankit Uniyal, Vinod Tiwari, Takashi Tsukamoto, et al.
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 12, pp. 1009-1027
Open Access | Times Cited: 11
Modulation of the endocannabinoid system in chronic conditions: a potential therapeutic intervention yet to be explored in sickle cell disease
Lucas Pereira de Souza, Juliana Paiva Gouvea Sicoli, Sara Teresinha Olalla Saad, et al.
Expert Review of Hematology (2025)
Closed Access
Pathophysiology and Therapeutic Perspectives for Chemotherapy-induced Peripheral Neuropathy
Avallone Antonio, Sabrina Bimonte, Claudia Cardone, et al.
Anticancer Research (2022) Vol. 42, Iss. 10, pp. 4667-4678
Open Access | Times Cited: 17
Changes in the expression of endocannabinoid system components in an experimental model of chemotherapy-induced peripheral neuropathic pain: Evaluation of sex-related differences
María Victoria Noya-Riobó, Constanza Ágata Miguel, Delia Beatriz Soriano, et al.
Experimental Neurology (2022) Vol. 359, pp. 114232-114232
Closed Access | Times Cited: 16
G Protein-Coupled Receptors and Ion Channels Involvement in Cisplatin-Induced Peripheral Neuropathy: A Review of Preclinical Studies
Gabriela Becker, Samuel Felipe Atuati, Sara Marchesan Oliveira
Cancers (2024) Vol. 16, Iss. 3, pp. 580-580
Open Access | Times Cited: 3
The Interplay between 2-Arachidonoylglycerol and Anandamide Amidohydrolase in Neuropathy
Iddrisu Ibrahim, Joseph Ayariga, Junhuan Xu, et al.
(2024)
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top